You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Psoriasis

Ustekinumab for the treatment of adults with moderate to severe psoriasis

  • Technology appraisal guidance
  • Reference number: TA180
  • Published:  23 September 2009
  • Last updated:  03 March 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Consultee and commentator comments on the ACD

  • Janssen-Cilag

  • British Association of Dermatologists

  • Psoriasis and Psoriatic Arthritis Alliance

  • Royal College of Physicians

  • Royal College of Nursing

  • Department of Health

  • Dorset PCT

  • Welsh Assembly Government

  • Abbott Laboratories

  • Schering-Plough

  • Wyeth Pharmaceutical


This page was last updated: 30 March 2010

Back to top